NBSE

NeuBase Therapeutics, Inc. Common Stock

Delisted

NBSE was delisted on the 10th of May, 2024.

40 hedge funds and large institutions have $10.7M invested in NeuBase Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$140K
Puts
$146K
Net Calls
Net Calls Change

Top Buyers

1 +$936K
2 +$487K
3 +$429K
4
CC
Cannell & Co
New York
+$370K
5
Northern Trust
Northern Trust
Illinois
+$156K

Top Sellers

1 -$110K
2 -$45.5K
3 -$31.3K
4
VF
Virtu Financial
New York
-$24K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$23.8K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.04M
2
$1.95M
3
$1.23M
4
$915K
5
$912K
6
$779K
7
$258K
8
$257K
9
$161K
10
$147K
11
$122K
12
$115K
13
$86K
14
$74K
15
$74K
16
$64K
17
$56K
18
$52K
19
$48K
20
$47K
21
$42K
22
$41K
23
$37K
24
$35K
25
$26K